Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Potential nontraditional applications of statins.

James M McKenney1

  • 1School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA, USA. jmckenney@ncrinc.net

The Annals of Pharmacotherapy
|July 5, 2003
PubMed
Summary

Hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) show significant benefits beyond coronary artery disease. Evidence supports their use in acute coronary syndromes, stroke prevention, and potential roles in peripheral arterial disease, renal disease, and diabetes mellitus.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lipid lowering with bempedoic acid added to a proprotein convertase subtilisin/kexin type 9 inhibitor therapy: A randomized, controlled trial.

Journal of clinical lipidology·2021
Same author

Pharmacodynamic relationship between PCSK9, alirocumab, and LDL-C lowering in the ODYSSEY CHOICE I trial.

Journal of clinical lipidology·2020
Same author

Alirocumab in high-risk patients: Observations from the open-label expanded use program.

Journal of clinical lipidology·2018
Same author

Efficacy and Safety of Alirocumab Versus Ezetimibe Over 2 Years (from ODYSSEY COMBO II).

The American journal of cardiology·2017
Same author

Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance.

Journal of clinical lipidology·2016
Same author

Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy.

The American journal of cardiology·2016

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Statins are primarily known for managing hypercholesterolemia and preventing coronary atherosclerosis.
  • Emerging research explores their broader therapeutic applications in various cardiovascular and non-cardiovascular conditions.

Purpose of the Study:

  • To review existing evidence on statin use in non-traditional lipid-related conditions.
  • To identify ongoing clinical trials investigating statins in these new indications.

Main Methods:

  • A comprehensive MEDLINE literature search (1990-2002) was conducted using keywords related to cardiovascular events, diseases, and specific statins.
  • Relevant treatment guidelines from major health organizations were also reviewed.

Main Results:

Related Experiment Videos

  • Strong evidence supports statin efficacy in acute coronary syndromes.
  • Statins are proven to prevent both initial and recurrent strokes.
  • Emerging data suggest potential benefits in peripheral arterial disease, end-stage renal disease, and diabetes mellitus.

    • Conclusions:

    • A substantial body of evidence supports expanding the clinical evaluation of statins.
    • Statins show promise in managing conditions beyond coronary atherosclerosis prevention.